Caili Li
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.
Journal: Nature communications
Published: August 08, 2025
Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis.
Journal: Cancer investigation
Published: May 23, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma.
Journal: Cancer management and research
Published: February 05, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights.
Journal: Journal for immunotherapy of cancer
Published: January 19, 2025
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy.
Journal: Journal of extracellular vesicles
Published: September 12, 2024
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.
Journal: Clinical and translational medicine
Published: September 11, 2024
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 study.
Journal: Med (New York, N.Y.)
Published: September 02, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial.
Journal: Signal transduction and targeted therapy
Published: May 28, 2024
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Journal: EClinicalMedicine
Published: April 04, 2024
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study.
Journal: BMC cancer
Published: December 02, 2023
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study.
Journal: JAAD international
Published: November 18, 2023
Natural history of bone-only metastasis in renal cell carcinoma.
Journal: Urologic oncology
Published: September 01, 2023
Last Updated: 09/26/2026